1. resuscitation in pregnant women , surviving sepsis guidlines 2. ⁠LFT and their significane, child pugh score 3. ⁠usg guided adductor canal block, renal replacement therapy 4. ⁠types of labour analgesia, pain pathway in labour pain 5. anaesthesia challenges and mgt of posterior fossa tumour 6. ⁠airway management of maxillofacial trauma plus manual inline stabilization 7. ⁠anaesthesia mgt of 2 year old paediatric who has foreign body insertion taken for emergency 8. ⁠biochemical changes of stored blood, indication and complication of blood transfusion 9. link 25, electrical safety of OT 10. ⁠post op analgesia for paediatric in lower abdominal surgery and thoracotomy

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Searching the Web

surviving sepsis campaign 2024 guidelines resuscitation pregnant women

Here is a comprehensive structured review of all 10 topics:

Anaesthesia Comprehensive Review


1. Resuscitation in Pregnant Women + Surviving Sepsis Guidelines

Physiological Adaptations Relevant to Resuscitation

  • Aortocaval compression: From 20 weeks gestation, the gravid uterus compresses the IVC → reduced venous return → left lateral tilt 15–30° (wedge under right hip) is mandatory during CPR/resuscitation
  • Airway: Oedematous, Mallampati increases, higher risk of aspiration (reduced LOS tone, delayed gastric emptying) → early RSI with cricoid pressure
  • Respiratory: Increased O₂ consumption (20%), reduced FRC (20%) → desaturates faster; PaCO₂ normally 30 mmHg (respiratory alkalosis)
  • Cardiovascular: CO increases 40–50%, HR +15–20 bpm, SVR falls; BP normally lower
  • Blood: Dilutional anaemia (Hb ~11 g/dL), physiological hypercoagulability

Cardiac Arrest in Pregnancy — 4H4T + Perimortem Caesarean (PMCS)

StepAction
PositionLeft lateral tilt or manual uterine displacement
AirwayEarly intubation (aspiration risk), waveform capnography
CompressionsStandard 30:2, hard & fast, full chest recoil
PMCSIf no ROSC within 4 minutes → deliver baby by 5 minutes (improves maternal resuscitation)
DefibrillationSame energy as non-pregnant; remove fetal monitors first
Causes unique to pregnancy: Eclampsia/PE, peripartum cardiomyopathy, amniotic fluid embolism, Mg toxicity, aortocaval compression, haemorrhage

Surviving Sepsis Campaign Guidelines (SSC 2021 — "Hour-1 Bundle")

Definitions: Sepsis = life-threatening organ dysfunction caused by dysregulated host response to infection. Septic shock = vasopressor needed to maintain MAP ≥65 mmHg + lactate >2 mmol/L despite adequate resuscitation.

Hour-1 Bundle (initiate within 1 hour of recognition)

  1. Measure lactate (remeasure if >2 mmol/L)
  2. Blood cultures ×2 (before antibiotics; don't delay antibiotics >45 min)
  3. Broad-spectrum antibiotics within 1 hour
  4. 30 mL/kg crystalloid IV if hypotensive or lactate ≥4 mmol/L
  5. Vasopressors if MAP <65 mmHg during/after fluid — noradrenaline first-line

Additional SSC Targets

  • MAP ≥65 mmHg
  • ScvO₂ ≥70%, CVP 8–12 mmHg (or 12–15 if mechanically ventilated)
  • Urine output ≥0.5 mL/kg/hr
  • Glycaemic control: maintain blood glucose <10 mmol/L (180 mg/dL)
  • Corticosteroids: Hydrocortisone 200 mg/day IV if vasopressor-refractory shock
  • Lung-protective ventilation: Tidal volume 6 mL/kg IBW, Pplat <30 cmH₂O, PEEP as needed
  • Prone ventilation ≥16 hours/day if PaO₂/FiO₂ <150

Sepsis in Pregnancy — Special Considerations

  • Most common organisms: Group A Strep, E. coli, GBS
  • Avoid aminoglycosides if possible (nephrotoxicity)
  • Hydrocortisone safe in pregnancy
  • Delivery may be required to treat source (chorioamnionitis)
  • Normal WBC in pregnancy is 9,000–15,000 → sepsis harder to detect biochemically

2. Liver Function Tests (LFTs) and Significance + Child-Pugh Score

LFTs and Clinical Significance

TestNormalSignificance
Bilirubin (total)<17 µmol/LJaundice if >34; pre-hepatic (haemolysis), hepatic, post-hepatic (obstruction)
Bilirubin (direct/conjugated)<7 µmol/LElevated in hepatocellular disease or cholestasis
ALT (SGPT)7–56 U/LHepatocyte damage (liver-specific); hallmark of hepatitis
AST (SGOT)10–40 U/LLess specific — liver, heart, muscle; AST:ALT >2:1 → alcoholic liver disease
ALP30–120 U/LCholestasis, bone disease; isolated rise → biliary/infiltrative
GGT<55 U/LAlcohol abuse, biliary, enzyme inducer; sensitive marker
Albumin35–50 g/LSynthetic function; half-life 21 days — chronic disease marker
PT / INRINR <1.2Clotting factor synthesis (Factors I, II, V, VII, X); acutely sensitive to liver failure
Total Protein60–80 g/LIncludes albumin + globulins
Patterns:
  • Hepatocellular: ↑↑ ALT/AST, ↑ bilirubin, ↓ albumin, ↑ PT
  • Cholestatic: ↑↑ ALP/GGT, ↑ bilirubin, normal/mild ↑ transaminases
  • Synthetic failure: ↓ Albumin, ↑ INR/PT, ↑ bilirubin → suggests cirrhosis/acute liver failure

Anaesthetic Implications of LFT Abnormalities

  • Coagulopathy: Fresh frozen plasma, vitamin K, platelet transfusion
  • Hypoalbuminaemia: ↑ free fraction of protein-bound drugs (e.g. thiopental, benzodiazepines)
  • Ascites: Risk of regurgitation, diaphragm splinting, ↓ FRC
  • Hepatic encephalopathy: Avoid morphine, benzodiazepines
  • Avoid: Halothane (hepatotoxic), NSAIDS (renal + GI effects)
  • Drug metabolism: Reduced CYP450 activity → prolonged drug effects

Child-Pugh Score

Used to assess severity of liver disease and predict operative mortality.
Parameter1 point2 points3 points
Bilirubin (µmol/L)<3434–51>51
Albumin (g/L)>3528–35<28
PT Prolongation (sec)<44–6>6
AscitesNoneMild/controlledSevere/refractory
EncephalopathyNoneGrade 1–2Grade 3–4
ClassScore1-year survivalOperative mortality
A5–6100%2–10%
B7–980%~30%
C10–1545%~75–82%
Child-Pugh C patients are high surgical risk; elective surgery should be deferred. MELD score (Model for End-stage Liver Disease) is now preferred for transplant allocation.

3. USG-Guided Adductor Canal Block + Renal Replacement Therapy

USG-Guided Adductor Canal Block (ACB)

(Source: Morgan & Mikhail's Clinical Anesthesiology, 7e)
Anatomy: The adductor canal (Hunter's canal) is bounded by:
  • Sartorius muscle — medially
  • Vastus medialis — anteriorly
  • Adductor magnus & longus — posteriorly
Contents: Saphenous nerve, posterior branch of obturator nerve, nerve to vastus medialis, superficial femoral artery & vein
Indications: Knee surgery (TKA, ACL repair, meniscectomy), medial leg/ankle surgery; preferred over femoral nerve block as it preserves quadriceps strength, allowing earlier ambulation.
Technique (USG-guided):
  1. Position: Supine, leg externally rotated, knee slightly flexed
  2. Probe: High-frequency linear probe, transverse orientation, mid-thigh (halfway between ASIS and superior patellar pole)
  3. Identify: Femoral artery (pulsatile), vein (compressible), sartorius muscle superficially; saphenous nerve lies anterior to the artery (hyperechoic structure)
  4. Needle: In-plane technique, insert 2–3 cm lateral to probe, advance medially into the triangular space deep to sartorius, anterior to artery
  5. Confirm: Negative aspiration, spread of LA around nerve/artery
  6. Volume: 15–20 mL local anaesthetic (0.25–0.5% bupivacaine or 0.2% ropivacaine)
Advantages over femoral nerve block: No quadriceps weakness → earlier mobilisation; equivalent analgesia for knee surgery.
Continuous ACB: Catheter placed; useful post-TKA for 24–48 hours.
Positioning for adductor canal block
Positioning for adductor canal block — supine, leg externally rotated
Ultrasound image showing adductor canal anatomy
USG: SFA = superficial femoral artery; SFV = superficial femoral vein; SN = saphenous nerve

Renal Replacement Therapy (RRT)

Indications (mnemonic AEIOU):
  • A — Acidosis (metabolic, pH <7.1, refractory)
  • E — Electrolyte disturbance (hyperkalaemia >6.5, refractory)
  • I — Intoxication (dialysable toxins: lithium, salicylates, methanol, ethylene glycol, theophylline)
  • O — Overload (fluid overload refractory to diuretics)
  • U — Uraemia (uraemic pericarditis, encephalopathy, Urea >30 mmol/L)
Modalities:
ModeMechanismRateUse
IHD (Intermittent Haemodialysis)DiffusionFastStable CKD/AKI, toxin removal
CVVH (Continuous Veno-venous Haemofiltration)ConvectionSlowHaemodynamically unstable ICU
CVVHD (+ Dialysis)Diffusion + convectionSlowICU with metabolic derangement
CAVHArterio-venous (no pump)SlowRarely used
PD (Peritoneal Dialysis)Diffusion across peritoneumSlowPaediatric, home dialysis
SLED (Sustained Low Efficiency Dialysis)HybridMediumHaemodynamic instability
Continuous RRT (CRRT) is preferred in ICU because:
  • Better haemodynamic tolerance
  • Gradual fluid removal avoids cerebral oedema
  • Allows large volumes of IV drugs/nutrition
Anticoagulation for RRT: Unfractioned heparin (systemic), regional citrate anticoagulation (preferred — less bleeding risk), or no anticoagulation (high bleeding risk patients).

4. Types of Labour Analgesia + Pain Pathway in Labour Pain

Pain Pathway in Labour

First Stage of Labour (latent + active):
  • Pain from uterine contractions and cervical dilation
  • Transmitted via visceral afferents (C-fibres) → enter cord at T10–L1
  • Travel with sympathetic fibres through uterine and cervical plexuses → inferior hypogastric plexus → lumbar sympathetic chain → thoracic sympathetic chain → spinal cord T10–L1
Second Stage of Labour:
  • Pain from perineal distension and vaginal/pelvic floor stretching
  • Transmitted via somatic afferents (pudendal nerve, S2–4)
  • Combined visceral (T10–L1) + somatic (S2–4) pain
Pain character: First stage — dull, crampy, referred to lower abdomen, back, thighs; Second stage — sharp, perineal, burning

Types of Labour Analgesia

1. Neuraxial (Regional) — Gold Standard

a) Epidural Analgesia
  • Most commonly used; flexible
  • Space: L2-3 or L3-4; loss of resistance technique
  • Drug: Low-concentration bupivacaine (0.0625–0.1%) + fentanyl (2 µg/mL) or sufentanil
  • Techniques: Continuous infusion (CEI), PCEA (patient-controlled epidural), PIEB (programmed intermittent epidural bolus — superior)
  • Covers T10–L1 (1st stage) and S2–4 (2nd stage)
  • Side effects: Hypotension (treat with IV fluids, vasopressors), motor block, PDPH (dural puncture headache), instrumental delivery rate
b) Spinal Analgesia
  • Low-dose intrathecal: Bupivacaine 2.5 mg + fentanyl 25 µg
  • Rapid onset but limited duration (1.5–2 hours); not preferred alone for labour
c) Combined Spinal-Epidural (CSE)
  • Best of both: rapid onset of spinal + flexibility of epidural
  • Needle-through-needle technique
  • Intrathecal dose: bupivacaine 2.5 mg + fentanyl 25 µg
  • Ideal for advanced labour or when rapid analgesia needed
d) Dural Puncture Epidural (DPE)
  • Epidural needle + deliberate dural puncture (without injection); enhances epidural spread
  • Lower risk of PDPH than CSE

2. Systemic Opioid Analgesia

DrugRouteNotes
Pethidine (Meperidine)IM/IVMost used; CNS depression in neonate (norpethidine); avoid if delivery <4 hours
MorphineIMLess titratable; neonatal respiratory depression
FentanylIV/PCAShort-acting, better titratable; neonatal depression less
Remifentanil PCAIV PCAGrowing evidence; watch maternal respiratory depression; 1:1 nurse monitoring required
Remifentanil PCA: Bolus 0.25–0.5 µg/kg; lockout 2 min; comparable to epidural in some studies.

3. Inhaled Analgesia

  • Entonox (50% N₂O + 50% O₂): Self-administered; onset in 30–45 seconds; partial, not complete analgesia; nausea
  • Methoxyflurane (Penthrox): Inhaler device; effective, rapid onset

4. Regional Nerve Blocks

  • Pudendal nerve block: 2nd stage/instrumental delivery; 10 mL 1% lignocaine at ischial spine bilaterally; covers S2–4 (perineum only)
  • Paracervical block: Covers cervical afferents T10–L1; risk of fetal bradycardia (vasoconstriction of uterine artery); largely abandoned
  • Lumbar sympathetic block: Covers 1st stage (T10–L1) via bilateral L2–3 block

5. Non-Pharmacological

  • Hydrotherapy, TENS, massage, acupuncture, hypnobirthing — limited but real analgesic effect

5. Anaesthesia Challenges & Management of Posterior Fossa Tumour

Challenges

1. Positioning
  • Sitting position (most common for posterior fossa): Risk of Venous Air Embolism (VAE) — most dangerous complication; also risk of paradoxical air embolism if PFO present (check with bubble echo preop)
  • Other positions: Prone (Concorde), lateral, park-bench
  • Sitting position: Also risks pneumocephalus, haemodynamic instability, quadriplegia from neck flexion (≥2 finger-breadths between chin and chest)
2. Raised Intracranial Pressure (ICP)
  • Posterior fossa tumours → hydrocephalus (4th ventricle obstruction)
  • Manage: Head up 30°, avoid hypercapnia (PaCO₂ 34–38 mmHg), avoid hypoxia, judicious fluids (isotonic solutions, avoid glucose), mannitol 0.5–1 g/kg, dexamethasone
3. Venous Air Embolism (VAE)
  • Risk highest in sitting position (surgical site above heart level)
  • Detection (in order of sensitivity): TOE > precordial Doppler > capnography (ETCO₂ drop) > pulmonary artery catheter > CVP > clinical signs
  • Management of VAE: Flood field with saline, N₂O off immediately, left lateral Trendelenburg (Durant manoeuvre), aspiration via CVP catheter, vasopressors, CPR if cardiac arrest
4. Cranial Nerve & Brainstem Proximity
  • Risk of intraoperative injury to V, VI, VII, IX, X, XI, XII
  • Neuromonitoring: SSEP (somatosensory evoked potentials), BAEP (brainstem auditory), MEP (motor), facial nerve EMG — requires TIVA (avoid volatile agents which suppress evoked potentials)
5. Pneumocephalus
  • Air enters cranial vault during surgery; worsens with N₂O (enlarges air pockets) → avoid N₂O in sitting craniotomy; use TIVA

Anaesthesia Management

Preoperative:
  • Review MRI, assess ICP signs (headache, vomiting, papilloedema)
  • Neurological baseline
  • Steroids (dexamethasone 4–8 mg q6h) pre-operatively
  • Consent for sitting position: Doppler + CVC placement
Induction:
  • TIVA preferred (propofol + remifentanil infusion) — maintains neurological monitoring
  • Avoid ketamine (increases ICP)
  • Smooth induction: Prevent coughing/straining → IV lidocaine 1.5 mg/kg or remifentanil bolus before laryngoscopy
  • Hyperventilate mildly (PaCO₂ 34–36 mmHg)
Maintenance:
  • TIVA (propofol + remifentanil) if neuromonitoring in use
  • Or low-dose volatile (<0.5 MAC) + opioid if monitoring not required
  • Glucose-free isotonic fluids; avoid hypo-osmolar solutions
  • Maintain MAP 60–90 mmHg; cerebral perfusion pressure >60 mmHg
Monitoring:
  • Arterial line (BP beat-to-beat), CVC (VAE aspiration catheter at cavoatrial junction), ETCO₂, precordial Doppler, BIS/depth of anaesthesia, neuromonitoring probes, temperature
Sitting Position Precautions:
  • Avoid hypovolaemia before sitting (leg elevation, sequential compression devices)
  • Precordial Doppler or TOE in place before positioning
  • Adequate neck flexion check (2-finger breadth chin-chest distance)
Postoperative:
  • Awake extubation preferred (assess neurological status)
  • ICU/HDU
  • Dexamethasone continued
  • Monitor for: haematoma, pneumocephalus, cranial nerve deficits, hydrocephalus, cerebellar oedema
  • Tension pneumocephalus → causes "Mount Fuji sign" on CT → neurosurgical emergency

6. Airway Management of Maxillofacial Trauma + Manual Inline Stabilisation (MILS)

Challenges in Maxillofacial Trauma Airway

  • Distorted anatomy: Fractures (Le Fort I/II/III, mandibular, zygomatic), oedema, haematoma → difficult laryngoscopy
  • Blood in airway: Clots, active haemorrhage obscure the view
  • Trismus: Limited mouth opening
  • Aspiration risk: Blood, secretions, gastric contents (full stomach)
  • Associated C-spine injury: ~2–5% of maxillofacial trauma; assume C-spine injury until cleared
  • Unstable fractures: Mid-face fractures may allow inadvertent passage of instruments into cranial vault (cribriform plate breach)

Approach

Assessment (ABCDE first):
  • Check SpO₂, airway patency, respiratory rate
  • GCS, C-spine status, facial anatomy
  • Airway predictors: Blood, trismus, facial swelling, ability to open mouth, Mallampati (if possible), neck mobility
Airway Management Options (stepwise):
OptionIndication
RSI + direct laryngoscopyAdequate mouth opening, manageable haemorrhage
Video laryngoscopy (VL)First-line in anticipated difficult airway; improves C-spine alignment view
Awake Fibreoptic Intubation (AFOI)Anticipated very difficult airway, time permits, cooperative patient
Nasotracheal intubationTrismus; CONTRAINDICATED if cribriform plate fracture suspected (Le Fort II/III, basal skull fracture signs)
Surgical airwayCannot intubate, cannot oxygenate (CICO) → emergency cricothyroidotomy
Cricothyroidotomy (CICO):
  • Scalpel–bougie technique (preferred over needle): vertical skin incision → horizontal stab into CTM → bougie insertion → tube railroaded
  • Cannula cricothyroidotomy (4 mm kink-resistant catheter) as bridge

Manual Inline Stabilisation (MILS)

Principle: Maintains cervical spine in neutral position during laryngoscopy when C-spine collar is removed.
Why collar removed?: Rigid collar reduces mouth opening and worsens laryngoscopy → must remove it but must still protect C-spine.
Technique:
  1. A second operator stands to the side facing the patient's head
  2. Hands placed on mastoid processes (not mandible) and occiput — bilateral grip
  3. Applies gentle, firm counter-force against head/neck movement during laryngoscopy
  4. Does NOT improve the laryngoscopic view — may actually worsen glottic view (by preventing atlanto-occipital extension)
  5. Neutral position maintained, not immobilisation — allows mouth to open
Key Point: MILS does not prevent all spinal cord injury — it reduces excessive movement. If laryngoscopy view is poor, video laryngoscopy (hyperangulated blade) or flexible scope should be used.
RSI in C-spine injury:
  • Remove collar, apply MILS
  • Preoxygenate (high-flow O₂ 3 min or 8 vital capacity breaths)
  • Induction: Ketamine 1.5 mg/kg or thiopentone 3–5 mg/kg + suxamethonium 1.5 mg/kg
  • Sellick's manoeuvre (cricoid pressure) if aspiration risk
  • Video laryngoscopy preferred (GlideScope, C-MAC)
  • Have surgical airway immediately available

7. Anaesthesia Management of a 2-Year-Old with Foreign Body (Emergency)

Preoperative Assessment

History:
  • Nature, size, shape of foreign body (FB); when ingested
  • Airway vs oesophageal FB (stridor, wheeze, drooling vs dysphagia)
  • Last oral intake (full stomach — emergency)
  • Symptoms: Respiratory distress, cyanosis, drooling, complete vs partial obstruction
Examination:
  • SpO₂ on room air, RR, work of breathing, air entry
  • Stridor (inspiratory = supraglottic; expiratory = subglottic/tracheal; biphasic = fixed obstruction)
  • Signs of complete obstruction (silent chest, cyanosis) → immediate intervention
Investigations:
  • CXR (inspiratory/expiratory): Air trapping, hyperinflation, mediastinal shift (ball-valve FB in bronchus)
  • Lateral neck X-ray (radio-opaque FB)
  • CT scan if needed

Anaesthetic Challenges in a 2-Year-Old

  • Small airway → easy obstruction
  • High O₂ consumption → rapid desaturation
  • Small functional residual capacity
  • Uncooperative
  • Full stomach
  • Risk of pushing FB further or dislodging during induction

Anaesthetic Management

1. Preparation:
  • Senior anaesthetist, ENT surgeon scrubbed and ready, paediatric resuscitation equipment
  • Airway trolley: Range of ETT (uncuffed 4.5 for 2-year-old; ID = age/4 + 4 = 4.5), bronchoscopes (rigid + flexible), laryngoscopes (straight blade Miller 1–2)
  • Drugs: Atropine (0.02 mg/kg IV, minimum 0.1 mg — prevent bradycardia), induction agents
  • IV access established (EMLA cream)
2. Induction:
  • Gaseous induction with 100% O₂ + sevoflurane if IV access not established (maintains spontaneous ventilation, less likely to dislodge FB)
  • OR IV induction if IV access in place and child stable:
    • Propofol 2–3 mg/kg + dexamethasone 0.15 mg/kg (airway oedema)
    • Avoid suxamethonium if partial obstruction (loss of tone → complete obstruction risk — controversial; use clinical judgement)
    • Atropine before induction (bradycardia with sevo/rigid scope)
3. Airway Technique:
  • Rigid bronchoscopy (ENT/paediatric surgeons): For subglottic/tracheal/bronchial FB — maintain spontaneous or controlled ventilation through side port of bronchoscope
  • Direct laryngoscopy for supraglottic/laryngeal FB
  • Topical lignocaine on larynx (1 mg/kg max) to reduce laryngospasm
4. Ventilation Strategy:
  • Spontaneous ventilation preferred for airway FB (reduces risk of complete obstruction with positive pressure)
  • TPPR (Total intravenous + preserve respiration): Propofol + dexmedetomidine/remifentanil infusion
  • If IPPV needed: Low tidal volume, watch for air trapping
5. Emergency Considerations:
  • If complete obstruction: Back blows/chest thrusts (Paediatric BLS), emergency laryngoscopy
  • CICO: Needle cricothyroidotomy in child <12 years, jet ventilation
  • Post-extraction: Check for second FB, mucosal oedema (nebulised adrenaline 0.5 mL of 1:1000)
Postoperative:
  • Extubate awake, upright
  • Observe for laryngospasm, bronchospasm, oedema
  • Dexamethasone 0.15–0.3 mg/kg reduces post-extubation stridor
  • Nebulised adrenaline if stridor present

8. Biochemical Changes in Stored Blood + Indications & Complications of Blood Transfusion

Biochemical Changes in Stored Blood

Blood is stored in CPDA-1 (citrate-phosphate-dextrose-adenine) at 2–6°C for up to 35 days (SAGM up to 42 days).
ParameterChange with StorageClinical Significance
pH↓ (7.4 → ~6.7)Metabolic acidosis (citric acid, lactic acid accumulation)
pCO₂
pO₂
Potassium (K⁺)↑ (rises to 30–40 mmol/L)Hyperkalaemia — risk in rapid/massive transfusion, neonates, renal failure
Sodium (Na⁺)Slightly ↓
Calcium (Ca²⁺)↓ (citrate binds Ca²⁺)Hypocalcaemia → myocardial depression, coagulopathy
2,3-DPG↓↓ (significant after 1–2 weeks)Leftward shift of O₂ dissociation curve → ↓ O₂ delivery to tissues
ATP↓ RBC deformability, ↑ haemolysis
HaemoglobinUnchanged but function impaired
Clotting factors↓ significantlyAfter 5–7 days; FFP needed with massive transfusion
PlateletsNon-functional by day 1Platelets not present in packed RBCs (removed)
AmmoniaHepatic encephalopathy risk
MicroaggregatesForm over timeMicroemboli to lungs (filter with 40 µm filter for large volumes)
TemperatureCold (2–6°C)Hypothermia → worsens coagulopathy; use blood warmer
Storage lesion: Overall deterioration of RBC function (↑ haemolysis, ↓ deformability, ↑ adhesion, ↑ proinflammatory mediators, ↓ NO bioavailability).

Indications for Blood Transfusion

Packed Red Blood Cells (pRBCs):
  • Hb <7 g/dL (stable non-cardiac patients) — Restrictive trigger (TRICC criteria)
  • Hb <8 g/dL in cardiac surgery, ACS, orthopaedic surgery
  • Hb <10 g/dL in symptomatic patients (angina, dyspnoea, tachycardia)
  • Acute haemorrhage with haemodynamic instability (Class III/IV shock)
  • Symptomatic anaemia regardless of Hb level
FFP (Fresh Frozen Plasma):
  • PT/APTT >1.5× normal with active bleeding
  • Massive transfusion (1:1:1 ratio with RBCs:FFP:Platelets in military/trauma protocols)
  • Reversal of warfarin in emergency
  • DIC
  • TTP (plasma exchange)
Platelets:
  • Plt <10 × 10⁹/L (prophylactic)
  • Plt <50 × 10⁹/L with active bleeding or surgery
  • Plt <100 × 10⁹/L for neurosurgery/ophthalmic surgery
Cryoprecipitate:
  • Fibrinogen <1.5 g/L with bleeding
  • Haemophilia A, vWD, hypofibrinogenaemia, DIC

Complications of Blood Transfusion

IMMEDIATE (<24 hours):
ComplicationMechanismFeatures
AHTR (Acute Haemolytic Transfusion Reaction)ABO incompatibility; IgM antibody-mediatedFever, rigors, flank pain, haemoglobinuria, DIC, renal failure; STOP transfusion immediately
FNHTR (Febrile Non-Haemolytic)Recipient antibodies to donor WBCs/HLAFever, chills; most common; treat with paracetamol
Allergic/AnaphylacticAntibodies to donor plasma proteins (IgA deficiency)Urticaria → anaphylaxis; adrenaline
TRALI (Transfusion-Related Acute Lung Injury)Donor anti-HLA antibodies → neutrophil activation in lungsAcute hypoxia within 6 hours; non-cardiogenic pulmonary oedema; leading cause of transfusion death
TACO (Transfusion-Associated Circulatory Overload)Volume overloadHypertension, pulmonary oedema; diuretics
HypothermiaCold bloodArrhythmias, coagulopathy; use blood warmer
HyperkalaemiaK⁺ leakage from stored RBCsCardiac arrest especially in neonates/renal failure
HypocalcaemiaCitrate chelates Ca²⁺Tetany, myocardial depression; Ca gluconate IV
DICHaemolytic reaction or massive transfusion
DELAYED (>24 hours):
  • DHTR (Delayed Haemolytic): Non-ABO antibodies; mild, self-limited
  • TRALI (can be late)
  • Post-transfusion purpura: Platelet antibody, day 5–10
  • Graft-vs-Host Disease (TA-GvHD): Immunocompromised patients; fatal; prevent with irradiated blood
  • Infection: HIV, Hep B, Hep C, CMV, variant CJD, bacterial contamination (platelets at room temp → highest bacterial risk)
  • Iron overload: Repeated transfusions → haemosiderosis (chelation therapy)
  • Immunosuppression: Transfusion-related immunomodulation (TRIM)

9. Link 25 + Electrical Safety in the Operating Theatre

LINK 25 (Isolated Power Supply System)

Link 25 refers to the line isolation monitor (LIM) — part of the isolated (ungrounded) power supply system mandated in operating theatres in the UK (HTM 2007/HTM 06-01) and elsewhere.
Why isolated power in OT?
  • Standard grounded electrical systems: Any single fault can complete a circuit via earth → person touching live equipment is electrocuted (macroshock)
  • Isolated power system: The power supply transformer secondary winding is not connected to earth → a single fault to ground causes NO shock and no circuit breaker trip (power continues — essential in OT)
  • The LIM continuously monitors for total hazard current between isolated line conductors and earth
How Link 25 works:
  • When first fault occurs → LIM alarm activates (Link 25 panel shows alarm) but power NOT interrupted
  • This alerts staff to find and remove faulty equipment before a second fault creates a complete circuit
  • If a second fault occurs → circuit IS completed → shock hazard
  • LIM alarm threshold: 5 mA hazard current (some systems 2 mA)
In practice:
  • When Link 25 alarms → do not panic; power continues
  • Systematically identify and unplug equipment one by one until alarm clears
  • The last device unplugged is the faulty one

Electrical Safety in the Operating Theatre

Types of Electric Shock

TypeCurrentMechanism
Macroshock>1 mA felt; >100 mA VFCurrent through body surface → skin resistance; household current
Microshock>0.1 mA (100 µA) → VFCurrent directly to heart (pacing wires, intracardiac catheters) → bypasses skin resistance
Microshock is the primary OT concern — patients with intracardiac catheters are at risk from currents too small to feel.

Classification of OT Electrical Zones

  • Zone 1: General patient environment — standard safety
  • Zone 2: Cardiac procedures — isolated power supply, extra protection (IEC 60364-7-710)
  • All equipment must be Type CF (cardiac float protection) for procedures with intracardiac connection

Equipment Classifications

ClassProtectionExamples
Class IEarthingMost mains-powered devices
Class IIDouble insulation (no earth needed)Portable tools
Class IIISafety extra-low voltage <25V ACBattery-operated
Type BGeneral patient contactBP cuff, ECG
Type BFFloating (isolated) patient circuitStandard monitoring
Type CFCardiac floating circuit (microshock safe)Intracardiac devices, pacemakers

Diathermy Safety

  • Monopolar diathermy: Current enters via active electrode → disperses through body → exits via large patient plate (return electrode)
    • Plate must have full contact (burns if partial contact → current density ↑)
    • Avoid placing over bony prominences, scar tissue, implants
    • Interference with pacemakers → use bipolar diathermy or use asynchronous pacing mode
  • Bipolar diathermy: Current flows between two tips; localised; safer for cardiac devices and small structures
  • Capacitive coupling: In laparoscopy → current through insulation of laparoscopic instruments → bowel/vessel injury

Fire Triangle in OT

  • Oxidiser: O₂ or N₂O (enriched atmospheres)
  • Ignition: Diathermy, laser, cautery
  • Fuel: Surgical drapes, alcohol preps, ETT
  • Prevention: Use aqueous skin prep (not alcohol) near diathermy; no pooling of alcohol; oxygen-enriched atmosphere avoidance around ignition sources

Other Electrical Hazards

  • Static electricity: Detonation of flammable anaesthetic agents (historically with ether/cyclopropane — now abolished)
  • Lasers: CO₂, Nd:YAG — risk of ETT fire; use laser-resistant ETT, lowest FiO₂ possible
  • MRI: Ferromagnetic objects, pacemaker interference → specific MRI-compatible equipment required

10. Post-operative Analgesia for Paediatric Lower Abdominal Surgery & Thoracotomy

Principles of Paediatric Analgesia

  • Multimodal analgesia: Combining agents reduces total opioid requirements ("opioid-sparing")
  • WHO analgesic ladder (paediatric modification): Non-opioid → weak opioid → strong opioid
  • Doses are weight-based; children are NOT small adults
  • Pain assessment tools: FLACC (0–2 years), Wong-Baker FACES (3–7 years), NRS (>7 years)

Lower Abdominal Surgery (Inguinal Hernia, Circumcision, Orchidopexy, Appendicectomy)

Regional Techniques

BlockCoverageTechniqueDose
Caudal epiduralS2–T10 (depending on volume)Landmark or USG; sacral hiatus; 1–1.25 mL/kg0.2% bupivacaine (max 2 mg/kg); add adjuvants
Ilioinguinal/iliohypogastric nerve blockT12-L1; inguinal regionUSG-guided; lateral to ASIS; in-plane needle0.25% bupivacaine 0.1 mL/kg each side
TAP block (Transversus Abdominis Plane)T8-L1; anterior abdominal wallUSG; between internal oblique & TA0.25% bupivacaine 0.3 mL/kg each side (max 2.5 mg/kg total)
Penile nerve blockDorsal nerve of penis (for circumcision)Sub-pubic symphysis bilateral; avoid adrenaline0.25% bupivacaine 0.1 mL/kg
Rectus sheath blockPeriumbilical (T9–11)USG; lateral edge of rectusFor umbilical/midline incisions
Caudal epidural is the most commonly used single-shot regional technique for infants/children undergoing lower abdominal and perineal surgery. Adjuvants to prolong caudal:
  • Dexamethasone 0.1 mg/kg: Prolongs duration to ~12 hours
  • Dexmedetomidine 1 µg/kg: Prolongs to 10–14 hours
  • Clonidine 1–2 µg/kg: Prolongs to 6–10 hours
  • Ketamine 0.5 mg/kg (preservative-free): Prolongs to ~8 hours

Systemic Analgesia (all paediatric surgery)

  • Paracetamol: 15 mg/kg PO/IV q6h (max 60 mg/kg/day); safe in all ages
  • NSAIDS: Ibuprofen 5–10 mg/kg q6h (>3 months); diclofenac 1 mg/kg; avoid in neonates, renal impairment, asthma
  • Opioids (if needed): Morphine 0.1 mg/kg IV/IM (avoid in neonates <6 months — respiratory depression); consider PCA in >5 years

Thoracotomy in Paediatrics

Thoracotomy causes severe post-operative pain → impairs coughing, deep breathing → atelectasis, pneumonia. Aggressive analgesia is essential.

1. Thoracic Epidural Analgesia (TEA) — Gold Standard

  • Most effective for thoracotomy pain
  • Insert at T4–6 level (target dermatomal level T2–8)
  • Drug: Bupivacaine 0.1–0.125% + fentanyl 1–2 µg/mL infusion
  • Rate: 0.1–0.2 mL/kg/hr
  • Provides excellent post-op analgesia 48–72 hours
  • Facilitates early extubation, reduces lung complications
  • Risks: PDPH, epidural haematoma/abscess, hypotension, motor block

2. Paravertebral Block (PVB)

  • Excellent alternative if thoracic epidural contraindicated
  • Single injection or catheter
  • Unilateral analgesia (unlike bilateral epidural); less hypotension
  • USG-guided: Identify paravertebral space (loss of resistance / USG visualisation of pleural displacement)
  • Drug: 0.5 mL/kg bupivacaine 0.25–0.5% (max 2 mg/kg) per level; or catheter infusion
  • Advantages over TEA: Less haemodynamic instability, no urinary retention, easier in coagulopathy

3. Intercostal Nerve Blocks

  • Simple, effective; surgeon can inject under direct vision
  • Bupivacaine 0.25% 0.5 mL/kg per level (max 2 mg/kg total)
  • Short duration (4–6 hours); multiple levels required
  • Significant systemic absorption from intercostal space → toxicity risk (highest absorption rate of any block site)

4. Serratus Anterior Plane Block (SAPB)

  • USG-guided; between serratus anterior and latissimus dorsi
  • Covers T2–T9 lateral chest wall
  • Technically easier; no neuraxial risks
  • Increasing use in paediatric thoracic surgery

5. PECS II Block

  • USG-guided; covers medial/lateral pectoral nerves + intercostobrachial
  • Less evidence in children; used in older paediatric patients

6. Systemic Adjuncts

  • IV paracetamol 15 mg/kg q6h
  • Ketorolac 0.5 mg/kg q6h (>1 year; short course only)
  • IV morphine PCA (>5 years) or NCA (nurse-controlled) in younger
  • Dexmedetomidine infusion 0.2–0.5 µg/kg/hr (opioid-sparing, anxiolysis)
  • Gabapentin (limited paediatric evidence for post-thoracotomy)

ERAS for Paediatric Thoracotomy

  • Preoperative education, premedication (midazolam 0.5 mg/kg PO)
  • Regional anaesthesia first
  • Multimodal analgesia
  • Early oral feeding
  • Early physiotherapy and ambulation

Quick Reference Summary Table

TopicKey Points
Resuscitation in pregnancyLeft lateral tilt, early intubation, PMCS at 4 min; Surviving Sepsis Hour-1 bundle: lactate, cultures, antibiotics, 30 mL/kg fluid, noradrenaline
LFTs + Child-PughALT=hepatocellular; ALP=cholestatic; Albumin+PT=synthetic function; Child-Pugh A/B/C based on 5 parameters
Adductor canal blockSupine, linear probe mid-thigh, saphenous nerve anterior to SFA, 15–20 mL LA; preserves quadriceps
RRTAEIOU indications; CRRT preferred in ICU; CVVH (convection) vs IHD (diffusion)
Labour analgesiaCSE=gold standard (rapid onset + flexibility); pain T10–L1 (1st stage) + S2–4 (2nd stage)
Posterior fossaSitting position = VAE risk; TIVA for neuromonitoring; avoid N₂O; precordial Doppler; PMCS at 4 min → surgeon ready
Maxillofacial traumaMILS + collar off; VL preferred; avoid nasal intubation if basal skull fracture; scalpel-bougie for CICO
Paediatric FBGaseous induction (preserve spontaneous ventilation); rigid bronchoscopy; atropine premedication
Stored blood changes↓ pH, ↑ K⁺, ↑ CO₂, ↓ 2,3-DPG, ↓ Ca²⁺, ↓ clotting factors; TRALI = leading transfusion death
Link 25 + electrical safetyIsolated power supply; LIM alarms but doesn't cut power; macroshock vs microshock; Type CF for intracardiac
Paediatric post-op analgesiaLower abdominal: caudal ± adjuvants, TAP/ilioinguinal; Thoracotomy: thoracic epidural or paravertebral (gold standard)
This is a shared conversation. Sign in to Orris to start your own chat.